1 Erratum to: Clin Drug Investig DOI 10.1007/s40261-017-0532-1
The following correction should be noted:
Key Points, last sentence, which previously read:
There are reliable real-world data showing poroctant alfa is effective and well tolerated in children/infants with ARDS.
Should read:
There are reliable real-world data showing poractant alfa (Curosurf®) is effective and well tolerated in children/infants with ARDS.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1007/s40261-017-0532-1.
Rights and permissions
About this article
Cite this article
Amigoni, A., Pettenazzo, A., Stritoni, V. et al. Erratum to: Surfactants in Acute Respiratory Distress Syndrome in Infants and Children: Past, Present and Future. Clin Drug Investig 37, 711 (2017). https://doi.org/10.1007/s40261-017-0544-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40261-017-0544-x